Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by DLA Piper Australia ordered by Published Date Descending.
Links to Result pages
 
1 2  
>>Next
 
Title
Country
Organisation
Author
Date
1
Best practice disclosure for Life Sciences companies
The ASX and Ausbiotech have released the second edition of the "Code of Best Practice for Reporting by Life Sciences Companies".
Australia
10 Sep 2013
2
Boosting capital raisings for mid/small caps on Australian Securities Exchange
Given the size of most ASX-listed Life Sciences companies, this recent ASX amendment is very significant for the sector.
Australia
11 Jun 2013
3
Federal Court hands down decision of Cancer Voices Australia v Myriad Genetics Inc
This case concerned whether a valid patent could be granted for a claim that covered naturally occurring DNA or RNA.
Australia
19 Feb 2013
4
Australia's changing patent law landscape
The patent law landscape for life science companies in Australia may change significantly in 2012 with new legislation.
Australia
1 Mar 2012
5
Health Alert - 11 April 2011
Welcome to this week's edition of Health Alert. The Health Alert is transmitted on Monday of each week (unless there is a public holiday on Monday). Health Alert is a summary of the critical judgments, legislation, press releases and news items which have come to our attention each week. Many of the summaries will contain a hyperlink. If an item is of special interest, we may insert commentary into the body of Health Alert. However in general, Health Alert is a quick and effective means of en
Australia
11 Apr 2011
6
Health Alert - 13 December 2010
Health Alert is a summary of the critical judgments, legislation, press releases and news items which have come to our attention each week. Many of the summaries will contain a hyperlink. If an item is of special interest, we may insert commentary into the body of Health Alert. However in general, Health Alert is a quick and effective means of ensuring that you are aware of significant recent changes with little or no commentary from us.
Australia
13 Dec 2010
7
New code of good manufacturing practice for medicinal products
On 29 July 2009, the Therapeutic Goods (Manufacturing Principles) Determination No 1 of 2009 adopted the Guide to Good Manufacturing Practice - 15 January 2009 as issued by the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S) to become the new Code of Good Manufacturing Practice for Medicinal Products (New GMP). The New GMP became mandatory from 1 July 2010.
Australia
18 Nov 2010
8
END OF LIFE DECISIONS: H LIMITED v J [2010] SASC 176
On 19 January 2010, J wrote to H Limited, the Aged care facility where she resides, informing it of her decision to end her life by refusing food, water and insulin, upon which she is dependent. On 4 March she made an anticipatory directive that should she be in a terminal phase of a terminal illness or in a persistent vegetative state, H Ltd should only administer palliative care and provide neither hydration nor nutrition.
Australia
18 Nov 2010
9
Recent developments in embryonic stem cell research and biological therapies
Stem cells are seen as the next frontier of medical research as it is hoped their capacity to repair damaged cells may provide clues to the treatment of many currently incurable diseases. Stem cells are categorised as adult, embryonic or induced pluripotent (adult cells that are reprogrammed to act as embryonic stem cells).
Australia
18 Nov 2010
10
Genetic Information - Use and Disclosure to a Patient's Genetic Relatives
The National Health and Medical Research Council has recently released new Guidelines for Health Practitioners in the Private Sector on the Use and Disclosure of Genetic Information to a Patient’s Genetic Relatives.
Australia
7 Apr 2010
11
University of Western Australia v Gray - Medical Research IP Rights: Who Owns Them ?
Hospitals who wish to commercially benefit from health and medical research need to know who is involved in that research, their level of contribution and their relationship with the hospital.
Australia
7 Apr 2010
12
Grace Periods and Divisional Patent Applications
Recent case law confirms the priority date of a divisional patent application is the priority date of the parent patent application.
Australia
7 Apr 2010
13
Health Practitioner Registration - A New National Scheme
A new National Registration and Accreditation Scheme for Health Professionals begins on 1 July 2010.
Australia
 
6 Apr 2010
14
Advance Care Directives - Hunter and New England Health Service v A [2009] NSWSC 761
A recent decision by the Supreme Court of New South Wales in Hunter and New England Area Health Service v A [2009] NSWSC 761 has set out a useful set of principles for hospitals to follow in relation to advance care directives.
Australia
6 Apr 2010
15
Regulatory Reform: In Brief
Critical legislative reform in relation to the regulation of therapeutic goods are now a reality with recent measures passed by the Federal Government.
Australia
14 Oct 2009
16
European Developments: To Regulate Or Not To Regulate - That Is The Question?
Australian manufacturers and suppliers who export products to the EU should keep in mind that reforms across a number of fronts could have an impact on their business.
Australia
12 Oct 2009
17
One For All, And All For One? A Unified Approach To Therapeutic Goods Promotion
Government-led consideration is currently being given to whether a single code should apply to medical devices and technology, pharmaceuticals (including generics) and complementary medicines.
Australia
9 Oct 2009
18
Lab Tests Wins Back Lab Services Contract
The recent decision of the Court of Appeal has quashed the decision of the High Court which invalidated not only the decision of the Auckland Regional District Health Boards (ARDHBs) to award the contract to provide primary referred pathology services to Lab Tests but also the contract itself which was due to commence on 1 July 2007.
New Zealand
3 Nov 2008
19
Royalty Stacking & Managing The Risk Of IP Infringement
Royalty stacking and managing the risk of IP infringement in biotech product development - is the 'cure' more dangerous than the 'disease'?
Australia
13 Aug 2008
20
University IP: Actively Managing The Commercial Profit Pie
The bionic ear developed through the University of Melbourne has revolutionised the way the medical world approaches hearing. Implanted in more than 50,000 people in 120 countries, it is a true story of success.
Australia
20 Nov 2007
Links to Result pages
 
1 2  
>>Next